Sol-Gel Technologies Price to Free Cash Flow Ratio 2016-2024 | SLGL

Historical price to free cash flow ratio values for Sol-Gel Technologies (SLGL) since 2016. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sol-Gel Technologies Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-11-21 0.48 0.00
2024-06-30 0.89 $-0.63 0.00
2024-03-31 0.98 $-0.66 0.00
2023-12-31 1.11 $-0.66 0.00
2023-09-30 1.63 $-0.42 0.00
2023-06-30 2.99 $-0.43 0.00
2023-03-31 3.88 $-0.42 0.00
2022-12-31 4.56 $-0.42 0.00
2022-09-30 5.02 $-0.34 0.00
2022-06-30 4.10 $-0.13 0.00
2022-03-31 7.38 $-0.34 0.00
2021-12-31 7.40 $-0.34 0.00
2021-09-30 10.00 $-1.14 0.00
2021-06-30 12.38 $-1.20 0.00
2021-03-31 12.38 $-1.14 0.00
2020-12-31 9.79 $-1.14 0.00
2020-09-30 7.24 $-1.18 0.00
2020-06-30 8.95 $-0.92 0.00
2020-03-31 7.06 $-1.18 0.00
2019-12-31 17.15 $-1.18 0.00
2019-09-30 8.99 $-0.47 0.00
2019-06-30 9.11 $-1.16 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.015B $0.002B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.395B 6.36
Dr Reddy's Laboratories (RDY) India $11.853B 22.68
BridgeBio Pharma (BBIO) United States $4.426B 0.00
Bausch Health Cos (BHC) Canada $2.931B 2.13
Amphastar Pharmaceuticals (AMPH) United States $2.186B 13.14
Supernus Pharmaceuticals (SUPN) United States $2.000B 27.23
Taysha Gene Therapies (TSHA) United States $0.506B 35.29
Personalis (PSNL) United States $0.245B 0.00
Assembly Biosciences (ASMB) United States $0.096B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00